Top Markets
Coin of the day
Sartorius Aktiengesellschaft Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

SOAGY
Classifica tra le azioni #317
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and... Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Prezzo delle azioni
$47.54
Capitalizzazione di mercato
$69.46B
Variazione (1 giorno)
-3.59%
Variazione (1 anno)
-9.07%
Paese
DE
Scambia Sartorius Aktiengesellschaft (SOAGY)

Categoria

Rapporto P/E per Sartorius Aktiengesellschaft (SOAGY)
Rapporto P/E al March 2026 TTM: 107.05
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Sartorius Aktiengesellschaft, il rapporto P/E attuale (TTM) è 107.05. Alla fine del 2023, il rapporto P/E era 115.13.
Storico del rapporto P/E per Sartorius Aktiengesellschaft da 2002 a 2026
Rapporto P/E alla fine di ogni anno
Anno Rapporto P/E Cambia
2026 (TTM) 107.05 -39.42%
2024 176.71 53.49%
2023 115.13 315.95%
2022 27.68 -70.98%
2021 95.37 30.42%
2020 73.13 22.59%
2019 59.65 12.80%
2018 52.88 10.69%
2017 47.78 2.00%
2016 46.84 44.32%
2015 32.46 -8.75%
2014 35.57 26.42%
2013 28.13 16.57%
2012 24.14 110.44%
2011 11.47 -23.94%
2010 15.08 -94.58%
2009 278.35 3,158.24%
2008 8.54 -43.48%
2007 15.12 -20.87%
2006 19.10 20.76%
2005 15.82 -7.24%
2004 17.05 -33.05%
2003 25.47 79.68%
2002 14.18 0.00%
Rapporto P/E per aziende simili o concorrenti
Azienda P/E Ratio Differenza del P/E Ratio Il paese
62.57 -41.55%
US
28.63 -73.25%
US
38.22 -64.30%
JP
43.53 -59.34%
CH
25.26 -76.40%
US
Come leggere un P/E ratio?

Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.

Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.

Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.